Several markers significantly correlated with CD3 expression in the tumour compartment, including CD40, CD44, CD14, B2M, Tim-3, CD8, CD45RO, and ICOS, potentially implicating other cell lineages in immune-associated anti-tumour activity. This evidence concerns the gene ICOS and neoplasm.